Výsledky vyhledávání - "HIV Seropositivity/drug therapy"

The importance of taking ART appropriately in children and adolescents with HIV-1 to reach the highest capacity of immune function later in life

Autor: Katrine Schou Sandgaard, Triantafylia Gkouleli, Teresa Attenborough, Stuart Adams, Deena Gibbons, Mette Holm, Sarah Eisen, Helen Baxendale, Anita De Rossi, Savita Pahwa, Benny Chain, Athina S. Gkazi, Nigel Klein

Publikováno v: Sandgaard, K S, Gkouleli, T, Attenborough, T, Adams, S, Gibbons, D, Holm, M, Eisen, S, Baxendale, H, De Rossi, A, Pahwa, S, Chain, B, Gkazi, A S & Klein, N 2022, ' The importance of taking ART appropriately in children and adolescents with HIV-1 to reach the highest capacity of immune function later in life ', Frontiers in Immunology, vol. 13, 860316 . https://doi.org/10.3389/fimmu.2022.860316

Current antiretroviral therapy (ART) guidelines recommend treating all children with HIV-1 infection. This has changed from the broader use of ART to treat children to improve morbidity and minimise mortality. However, prior to current recommendation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07bfacb94d06c8c7b674829fb3b31712
https://pubmed.ncbi.nlm.nih.gov/35967315

Zobrazit plný text záznamu

Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial

Autor: Sculier, Delphine, Wandeler, Gilles, Yerly Ferrillo, Sabine, Marinosci, Annalisa, Stoeckle, Marcel, Bernasconi, Enos, Braun, Dominique L., Vernazza, Pietro, Cavassini, Matthias, Buzzi, Marta, Metzner, Karin J., Decosterd, Laurent A., Günthard, Huldrych F., Schmid, Patrick, Limacher, Andreas, Egger, Matthias, Calmy, Alexandra, Swiss HIV Cohort Study (SHCS)

Publikováno v: PLoS Medicine
PLOS Medicine, Vol. 17, No 11 (2020) P. e1003421
PLoS Medicine, Vol 17, Iss 11, p e1003421 (2020)
PLoS medicine, vol. 17, no. 11, pp. e1003421
Sculier, Delphine; Wandeler, Gilles; Yerly, Sabine; Marinosci, Annalisa; Stoeckle, Marcel; Bernasconi, Enos; Braun, Dominique L; Vernazza, Pietro; Cavassini, Matthias; Buzzi, Marta; Metzner, Karin J; Decosterd, Laurent A; Günthard, Huldrych F; Schmid, Patrick; Limacher, Andreas; Egger, Matthias; Calmy, Alexandra (2020). Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial. PLoS medicine, 17(11), e1003421. Public Library of Science 10.1371/journal.pmed.1003421

Background Dolutegravir (DTG)–based dual therapy is becoming a new paradigm for both the initiation and maintenance of HIV treatment. The SIMPL’HIV study investigated the outcomes of virologically suppressed patients on standard combination antir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bdd4c65511c7d667a0d2980ff73e398
https://pubmed.ncbi.nlm.nih.gov/33170863

Zobrazit plný text záznamu

Plný text ve formátu HTML

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

Publikováno v: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2019, 74 (5), pp.1368-1375. ⟨10.1093/jac/dkz021⟩
Journal of Antimicrobial Chemotherapy, 2019, 74 (5), pp.1368-1375. ⟨10.1093/jac/dkz021⟩

International audience; Objectives: To describe integrase strand transfer inhibitor (INSTI) resistance profiles and factors associated with resistance in antiretroviral-naive and -experienced patients failing an INSTI-based regimen in clinical practi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b81aa0dcf188502b617cb295d23cbb
https://hal-normandie-univ.archives-ouvertes.fr/hal-02154049

Zobrazit plný text záznamu

Antiretroviral resistance testing in HIV-positive people

Autor: Theresa Aves, Joshua Tambe, Reed A C Siemieniuk, Lawrence Mbuagbaw

Publikováno v: The Cochrane Database of Systematic Reviews

Background Resistance to antiretroviral therapy (ART) among people living with human immunodeficiency virus (HIV) compromises treatment effectiveness, often leading to virological failure and mortality. Antiretroviral drug resistance tests may be use

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23a614b9ef0760c9885353f06b8849b6
https://doi.org/10.1002/14651858.cd006495.pub5

Zobrazit plný text záznamu

Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial

Autor: M. P. Glauser, Jean-Luc Pagani, Chantal Casjka, J. P. Chave, Jacques Bille

Publikováno v: The Journal of antimicrobial chemotherapy, vol. 50, no. 2, pp. 231-240

Over 37 months, we conducted a prospective double-blind, randomized study in a cohort of 138 HIV-infected patients to compare the effect of two different strategies on the prevention and treatment of oropharyngeal candidiasis relapses and on the deve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18a725e56d7b4206d2a08104f810e757
http://doc.rero.ch/record/301917/files/dkf101.pdf

Zobrazit plný text záznamu

Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics

Publikováno v: International Journal of Epidemiology
International Journal of Epidemiology, 2012, 41 (6), pp.1807-20. ⟨10.1093/ije/dys164⟩
International Journal of Epidemiology, Oxford University Press (OUP), 2012, 41 (6), pp.1807-20. ⟨10.1093/ije/dys164⟩
International Journal of Epidemiology, 41(6), 1807-1820
University of Helsinki
International journal of epidemiology, 41(6), 1807-1820. Oxford University Press
International Journal of Epidemiology; Vol 41
International Journal of Epidemiology, 41(6), 1807-20. Oxford University Press
Repositori Institucional de la Universitat Rovira i Virgili
Consejo Superior de Investigaciones Científicas (CSIC)

Background: HIV cohort collaborations, which pool data from diverse patient cohorts, have provided key insights into outcomes of antiretroviral therapy (ART). However, the extent of, and reasons for, between-cohort heterogeneity in rates of AIDS and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8dda77070396fdb52147571312af285
http://hdl.handle.net/11391/1328920

Zobrazit plný text záznamu

VIH/SIDA

Autor: Calmy, Alexandra, Cavassini, M

Publikováno v: Revue médicale suisse, Vol. 8, No 324 (2012) pp. 130-4

Thirty years after the first described AIDS case, fifteen years after the advent of highly active antiretroviral therapy, miracles continue. 2011 has seen important developments, notably in the fields of prevention and of antiretroviral treatment. Co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1400::82e154c61ae410b9d271f55b55ec4952
https://archive-ouverte.unige.ch/unige:31598

Zobrazit plný text záznamu

Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis

Autor: Thierry Kuntzer, Matthias Cavassini, Jan Novy, R. Du Pasquier, Antonio Carota

Publikováno v: Neurology, vol. 76, no. 8, pp. 757-758

There exists almost no literature on how to treat myasthenia gravis (MG) in HIV-infected patients. We report a 21-year-old HIV+ African woman (A3 Centers for Disease Control and Prevention staging) who developed a bulbar form of MG concomitant with s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9e60b61deb568357ddca3cbada51836
https://doi.org/10.1212/wnl.0b013e31820d6290

Zobrazit plný text záznamu

Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000

Autor: Bruno Ledergerber, Josef Jost, Bernard Hirschel, Enos Bernasconi, Philippe Sudre, Patrick Francioli

Publikováno v: Swiss medical weekly, vol. 131, no. 29-30, pp. 433-437
Swiss Medical Weekly, Vol. 131, No 29-30 (2001) pp. 433-437

OBJECTIVE: To analyse the data from Swiss nationwide voluntary reporting on non-occupational HIV-postexposure prophylaxis (HIV-PEP) by prescribing physicians. METHODS: One hundred and seventy-six persons, who received antiretroviral prophylaxis for c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9dce58e21f57a4aed218bf466cf5ca
https://serval.unil.ch/notice/serval:BIB_2BBD0D5C311D

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání